Internal Medicine · La Mesa, CA
NPI
1124393210
Since 2012
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8080 Parkway Dr
La Mesa, CA, 91942
Phone (619) 528-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$902
15 services
Medicare patients, 2024
11
Average age 73
Drug cost, 2024
$475K
10,603 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jesse Lyon prescribed most often to Medicare patients was Atorvastatin Calcium, with 966 prescriptions and refills. In total Jesse Lyon wrote 10,603 Medicare prescriptions that cost $475K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 966 | 3,025 | 327 | $12K |
| Rosuvastatin Calcium Generic | 532 | 1,728 | 184 | $6,211 |
| Losartan Potassium Generic | 457 | 1,403 | 157 | $6,202 |
| Metformin Hcl Er Metformin Hcl | 411 | 1,332 | 145 | $3,483 |
| Amlodipine Besylate Generic | 409 | 1,245 | 141 | $5,034 |
| Lisinopril Generic | 407 | 1,285 | 140 | $5,272 |
| Levothyroxine Sodium Generic | 348 | 1,094 | 106 | $6,506 |
| Omeprazole Generic | 253 | 588 | 105 | $2,715 |
| Terazosin Hcl Generic | 237 | 604 | 71 | $14K |
| Gabapentin Generic | 220 | 512 | 91 | $4,738 |
| Meloxicam Generic | 214 | 357 | 80 | $1,675 |
| Hydrochlorothiazide Generic | 195 | 590 | 64 | $2,198 |
| Metformin Hcl Generic | 191 | 516 | 59 | $2,242 |
| Metoprolol Tartrate Generic | 191 | 530 | 61 | $1,978 |
| Sertraline Hcl Generic | 188 | 520 | 66 | $2,919 |
Brand drugs: 947 claims; generic drugs: 9,560 claims; opioid claims: 125.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jesse Lyon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.